What problem does it solve?
GWAS identifies trait-associated genomic regions, but linkage disequilibrium makes it hard to pinpoint the actual causal variant — the lead SNP is often just the best-tagged marker, not the cause. This Skill applies statistical fine-mapping results (SuSiE, FINEMAP) and locus-to-gene (L2G) predictions from Open Targets Genetics and the GWAS Catalog to identify likely causal variants and their effector genes.
Core Features & Use Cases
- Credible Set Analysis: Retrieve fine-mapped credible sets for a variant, gene, or entire GWAS study, with posterior probabilities indicating each variant's likelihood of being causal.
- Locus-to-Gene Prioritization: Rank candidate effector genes by L2G score integrating distance, eQTL evidence, chromatin interactions, and functional annotations — avoiding the often-wrong 'nearest gene' assumption.
- Validation Guidance: Generate experimental validation suggestions (CRISPR knock-in, reporter assays, colocalization) based on fine-mapping results.
- Use Case: Ask which variant at the TCF7L2 locus is likely causal for type 2 diabetes, and receive the credible set, posterior probabilities, and top L2G gene predictions.
Quick Start
Ask the agent to fine-map rs7903146 and identify the likely causal variant and target gene at that locus.